Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | FAAH | O00519 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | GNAI3 | P08754 | 2/20 | 0.42 |
| ▸ | GNAO1 | P09471 | 2/20 | 0.42 |
| ▸ | GNAI1 | P63096 | 2/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.40 |
| ▸ | NAAA | Q02083 | 3/20 | 0.39 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.37 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.37 |
| ▸ | TRPV1 | Q8NER1 | 4/20 | 0.37 |
| ▸ | CNR1 | P21554 | 2/20 | 0.37 |
| ▸ | CNR2 | P34972 | 2/20 | 0.37 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.36 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL9844379 | 0.96 | FAAH (0.40) | MEN1KMT2AFAAHMAPK1GNAI3 | |
| Phosphoric Acid SCHEMBL9844245 | 0.95 | MEN1 (0.40) | MEN1KMT2AFAAHMAPK1GNAI3 | |
| Lactic Acid SCHEMBL427895 | 0.93 | FAAH (0.42) | MEN1KMT2AFAAHMAPK1GNAI3 | |
| Citric Acid SCHEMBL9844147 | 0.89 | PLA2G2C (0.35) | MEN1KMT2AFAAHMAPK1GNAI3 | |
| Lactic Acid SCHEMBL8519517 | 0.87 | FAAH (0.37) | MEN1KMT2AFAAHMAPK1GNAI3 | |
| SCHEMBL17688821 | 0.80 | SLC6A2 (0.37) | MEN1KMT2AMAPK1ALDH1A1 | |
| Lactic Acid SCHEMBL27574483 | 0.76 | SLC6A2 (0.35) | MEN1KMT2AMAPK1GNAI3GNAO1 | |
| SCHEMBL1413738 | 0.76 | SLC6A2 (0.34) | MEN1KMT2AMAPK1GNAI3GNAO1 | |
| SCHEMBL7795341 | 0.75 | SLC6A2 (0.34) | MEN1KMT2AMAPK1ALDH1A1 | |
| SCHEMBL27555097 | 0.75 | SLC6A2 (0.40) | MEN1KMT2AFAAHMAPK1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2393469-B1 | Process of treating hair | RHODIA OPERATIONS (FR) | 2016-10-12 | — | — | EP | claimed |
| EP-2424354-A2 | MOISTURIZING ANTIMICROBIAL COMPOSITION | Signal Investment & Management Co. (US) | 2012-03-07 | — | — | EP | claimed |
| US-20100278906-A1 | MOISTURIZING ANTIMICROBIAL COMPOSITION | GOLD BOND CO LLC | 2010-11-04 | — | — | US | claimed |
| WO-2010127231-A2 | MOISTURIZING ANTIMICROBIAL COMPOSITION | SIGNAL INVESTMENT AND MANAGEMENT CO. (US) | 2010-11-04 | — | — | WO | claimed |
| US-20080113892-A1 | Antimicrobial wash formulations including amidoamine-based cationic surfactants | SILVER POINT FINANCE, LLC, AS COLLATERAL AGENT | 2008-05-15 | — | — | US | claimed |
| US-20020155962-A1 | Nonaqueous hair styling composition and method of use | ANDREW JERGENS COMPANY, THE | 2002-10-24 | — | — | US | claimed |
| WO-1999053890-A1 | CONDITIONING SHAMPOO | AMWAY CORPORATION (US) | 1999-10-28 | — | — | WO | claimed |
| US-5945093-A | CONSISTS OF ANIONIC AND CATIONIC SURFACTANTS, AN ACID NEUTRALIZED AMIDONAMINE, WATER INSOLUBLE POLYSILOXANE AS CONDITIONING AGENT, DECADIENE CROSSLINKED MALEIC ANHDRIDE-METHYL VINYL ETHER COPOLYMER, FREE OF POLYHYDRIC COMPOUND | AMWAY CORPORATION (US) | 1999-08-31 | — | — | US | claimed |
| EP-0617953-B1 | Clear conditioning composition | CURTIS HELENE IND INC (US) | 1998-11-18 | — | — | EP | claimed |
| US-5556615-A | Clear conditioning composition | HELENE CURTIS, INC. (US) | 1996-09-17 | — | — | US | claimed |
| EP-0617953-A1 | Clear conditioning composition | Helene Curtis Industries, Inc. (US) | 1994-10-05 | — | — | EP | claimed |
| US-5328685-A | Amidoamine salt, silicone compound containing quaternary ammonium group | HELENE CURTIS, INC. (US) | 1994-07-12 | — | — | US | claimed |
| EP-0465734-B1 | Clear conditioning composition and method to impart improved properties to the hair | CURTIS HELENE IND INC (US) | 1994-03-02 | — | — | EP | claimed |
| US-5198209-A | Surfactants | AMWAY CORPORATION (US) | 1993-03-30 | — | — | US | claimed |
| EP-0465734-A1 | Clear conditioning composition and method to impart improved properties to the hair | HELENE CURTIS, INC. (US) | 1992-01-15 | — | — | EP | claimed |
| EP-0410659-A2 | Method and composition to impart improved conditioning properties to the hair | HELENE CURTIS, INC. (US) | 1991-01-30 | — | — | EP | claimed |
| US-4976956-A | Water soluble and oil soluble quaternary ammonium compounds and amidoamine | HELENE CURTIS, INC. (US) | 1990-12-11 | — | — | US | claimed |
| US-4954335-A | QUATERNARY AMMONIUM COMPOUND, AMIDOAMINE, POLYSILOXANE, NONIONIC SURFACTANT, ALCOHOL | HELENE CURTIS, INC. (US) | 1990-09-04 | — | — | US | claimed |
| US-12527733-B2 | Fragrance compositions | ELC MANAGEMENT LLC (US) | 2026-01-20 | — | — | US | disclosed |
| US-4954335-A | QUATERNARY AMMONIUM COMPOUND, AMIDOAMINE, POLYSILOXANE, NONIONIC SURFACTANT, ALCOHOL | HELENE CURTIS, INC. (US) | 1990-09-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12527733-B2 | Fragrance compositions | CUTA, IL36G, TAS2R40 | MEN1 4864/4885KMT2A 4603/4885FAAH 64/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.